scispace - formally typeset
M

Megan L. Mucksavage

Researcher at University of Pennsylvania

Publications -  8
Citations -  2572

Megan L. Mucksavage is an academic researcher from University of Pennsylvania. The author has contributed to research in topics: Cholesterol & Gene. The author has an hindex of 6, co-authored 8 publications receiving 2284 citations.

Papers
More filters
Journal ArticleDOI

Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis

TL;DR: Cholesterol efflux capacity from macrophages, a metric of HDL function, has a strong inverse association with both carotid intima-media thickness and the likelihood of angiographic coronary artery disease, independently of the HDL cholesterol level.
Journal ArticleDOI

Association of HDL cholesterol efflux capacity with incident coronary heart disease events: a prospective case-control study.

TL;DR: In this article, the authors measured cholesterol efflux capacity and assessed its relation with vascular risk factors and incident coronary heart disease events in a nested case-control sample from the prospective EPIC-Norfolk study of 25 639 individuals aged 40-79 years, assessed in 1993-97 and followed up to 2009.
Journal ArticleDOI

Human knockouts and phenotypic analysis in a cohort with a high rate of consanguinity.

TL;DR: Overall, these observations provide a roadmap for a ‘human knockout project’, a systematic effort to understand the phenotypic consequences of complete disruption of genes in humans.
Journal ArticleDOI

Causal Assessment of Serum Urate Levels in Cardiometabolic Diseases Through a Mendelian Randomization Study.

Tanya Keenan, +56 more
TL;DR: Evidence from this study does not support a causal role of circulating serum urate levels in T2DM, CHD, ischemic stroke, or HF, and decreasing serum Urate levels may not translate into risk reductions for cardiometabolic conditions.
Journal ArticleDOI

Extended-release Niacin Acutely Suppresses Postprandial Triglyceridemia

TL;DR: It is established that postprandial triglycerides suppression is an acute pharmacodynamic effect of extended-release niacin, probably the result of marked free fatty acid restriction.